The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
American Society of Clinical Oncology Statement: Toward Individualized Care for Patients With Advanced Cancer
Abstract
Patients with advanced incurable cancer face complex physical, psychological, social, and spiritual consequences of disease and its treatment. Care for these patients should include an individualized assessment of the patient's needs, goals, and preferences throughout the course of illness. Consideration of disease-directed therapy, symptom management, and attention to quality of life are important aspects of quality cancer care. However, emerging evidence suggests that, too often, realistic conversations about prognosis, the potential benefits and limitations of disease-directed therapy, and the potential role of palliative care, either in conjunction with or as an alternative to disease-directed therapy, occur late in the course of illness or not at all. This article addresses the American Society of Clinical Oncology's (ASCO's) vision for improved communication with and decision making for patients with advanced cancer. This statement advocates an individualized approach to discussing and providing disease-directed and supportive care options for patients with advanced cancer throughout the continuum of care. Building on ASCO's prior statements on end-of-life care (1998) and palliative care (2009), this article reviews the evidence for improved patient care in advanced cancer when patients' individual goals and preferences for care are discussed. It outlines the goals for individualized care, barriers that currently limit realization of this vision, and possible strategies to overcome these barriers that can improve care consistent with the goals of our patients and evidence-based medical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500 · cited 1×
“The current landscape of therapy for advanced cancer is rapidly evolving, and for several cancers, there are now interventions such as imatinib mesylate for chronic myelogenous leukemia or gastrointestinal stromal tumor and trastuzumab in human epidermal growth factor receptor 2 (HER2) –positive breast cancer that can…”
BackgroundBevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
Temel, J. S., Greer, J. A., Muzikansky, A., Gallagher, E. R., Admane, S., Jackson, V. A., Dahlin, C. M., Blinderman, C. D., Jacobsen, J., Pirl, W. F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000678 · Cited by 7,482
Coiffier, B., Lepage, E., Brière, J., Herbrecht, R., Tilly, H., Bouabdallah, R., Morel, P., Van Den Neste, E., Salles, G., Gaulard, P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011795 · Cited by 5,574
Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia
Druker, B. J., Guilhot, F., O'Brien, S. G., Gathmann, I., Kantarjian, H., Gattermann, N., Deininger, M. W. N., Silver, R. T., Goldman, J. M., Stone, R. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062867 · Cited by 3,488
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Lamon, D. E. J. S., Eyland, B. R. L., Hak, S. T. S., Uchs, H. A. F., Aton, V. I. P., Ajamonde, A. L. B., LeMing, T., Iermann, W. O. E., Olter, J. A. W., Egram, M. A. P., et al. (2009) · Cited by 1,199
Aggressiveness of Cancer Care Near the End of Life: Is It a Quality-of-Care Issue?
Earle, C. C., Landrum, M. B., Souza, J. M., Neville, B. A., Weeks, J. C., & Ayanian, J. Z. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.8253 · Cited by 949
Health Care Costs in the Last Week of Life: Associations With End-of-Life Conversations
Zhang, B., Wright, A. A., Huskamp, H. A., Nilsson, M. E., Maciejewski, M. L., Earle, C. C., Block, S. D., Maciejewski, P. K., & Prigerson, H. G. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.587 · Cited by 898 · cited 1×
“Such conversations may currently occur in 40% of patients with advanced cancer.(18,22) All patients are owed comprehensive information about their prognosis and treatment options, with the amount of detail tailored to the individual patient.”
BackgroundFallowfield, L., Jenkins, V., Farewell, V., Saul, J., Duffy, A., & Eves, R. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07810-8 · Cited by 854
Mack, J. W., Weeks, J. C., Wright, A. A., Block, S. D., & Prigerson, H. G. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.4672 · Cited by 806
Wright, A. A., Keating, N. L., Balboni, T. A., Matulonis, U. A., Block, S. D., & Prigerson, H. G. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3863 · Cited by 797
Ettinger, D. S., Akerley, W., Bepler, G., Blum, M. G., Chang, A., Cheney, R. T., Chirieac, L. R., D'Amico, T. A., Demmy, T. L., Ganti, A. K. P., et al. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0056 · Cited by 730
Raab, M. S., Podar, K., Breitkreutz, I., Richardson, P. G., & Anderson, K. C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60221-x · Cited by 697
American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care
Meropol, N. J., Schrag, D., Smith, T. J., Mulvey, T. M., Langdon, R. M., Blum, D., Ubel, P. A., & Schnipper, L. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.1183 · Cited by 638
Self-citationLara, P. N., Higdon, R., Lim, N., Kwan, K., Tanaka, M., Lau, D. H. M., Wun, T., Welborn, J., Meyers, F. J., Christensen, S., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1728 · Cited by 588
Barriers to Clinical Trial Participation by Older Women With Breast Cancer
Kemeny, M. M., Peterson, B. L., Kornblith, A. B., Muss, H. B., Wheeler, J., Levine, E., Bartlett, N., Fleming, G., & Cohen, H. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.124 · Cited by 465
Carlson, R. W., Allred, D. C., Anderson, B. O., Burstein, H. J., Carter, W. B., Edge, S. B., Erban, J. K., Farrar, W. B., Goldstein, L. J., Gradishar, W. J., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0012 · Cited by 450
Self-citationOncologist Communication About Emotion During Visits With Patients With Advanced Cancer
Pollak, K. I., Arnold, R. M., Jeffreys, A. S., Alexander, S. C., Olsen, M. K., Abernethy, A. P., Sugg Skinner, C., Rodriguez, K. L., & Tulsky, J. A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.4180 · Cited by 406
Ferris, F. D., Bruera, E., Cherny, N., Cummings, C., Currow, D., Dudgeon, D., JanJan, N., Strasser, F., von Gunten, C. F., & Von Roenn, J. H. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.1558 · Cited by 396 · cited 1×
“care, and a growth in the quantity and quality of research in this field.(2) Although widespread avail-”
BackgroundOncologists’ Attitudes Toward and Practices in Giving Bad News: An Exploratory Study
Baile, W. F., Lenzi, R., Parker, P. A., Buckman, R., & Cohen, L. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.004 · Cited by 366
How much is life worth: cetuximab, non-small cell lung cancer, and the $440 billion question
Fojo, T., & Grady, C. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp177 · Cited by 349
Physician factors associated with discussions about end‐of‐life care
Keating, N. L., Landrum, M. B., Rogers, S. O., Baum, S. K., Virnig, B. A., Huskamp, H. A., Earle, C. C., & Kahn, K. L. (2010) · Cancer · doi:10.1002/cncr.24761 · Cited by 345
Colon Cancer Clinical Practice Guidelines in Oncology
(2005) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2005.0024 · Cited by 315
Cancer care during the last phase of life.
(1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.5.1986 · Cited by 215
Patient–oncologist communication in advanced cancer: predictors of patient perception of prognosis
Robinson, T. M., Alexander, S. C., Hays, M., Jeffreys, A. S., Olsen, M. K., Rodriguez, K. L., Pollak, K. I., Abernethy, A. P., Arnold, R. M., & Tulsky, J. A. (2008) · Supportive Care in Cancer · doi:10.1007/s00520-007-0372-2 · Cited by 156
Health literacy, communication, and treatment decision-making in older cancer patients.
Amalraj, S., Starkweather, C., Nguyen, C., & Naeim, A. (2009) · PubMed · Cited by 150
Non-Small Cell Lung Cancer Guidelines
Ettinger, D. S., Bepler, G., Bueno, R., Chang, A. C., Chang, J. Y., Chirieac, L. R., D’Amico, T. A., Demmy, T. L., Feigenberg, S. J., Grannis, F. W., et al. (2006) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2006.0046 · Cited by 139
Joly, F., Vardy, J. L., Pintilie, M., & Tannock, I. F. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm121 · Cited by 126
Metastatic Renal Cell Carcinoma: Many Treatment Options, One Patient
Rini, B. I. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.9836 · Cited by 123
Faculty Development to Change the Paradigm of Communication Skills Teaching in Oncology
Back, A. L., Arnold, R. M., Baile, W. F., Tulsky, J. A., Barley, G. E., Pea, R. D., & Fryer-Edwards, K. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.2408 · Cited by 118
Colon Cancer Clinical Practice Guidelines in Oncology
Engstrom, P. F., Benson, A. B., & Saltz, L. B. (2003) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2003.0006 · Cited by 107
A Comprehensive Case Management Program To Improve Palliative Care
Spettell, C. M., Rawlins, W. S., Krakauer, R. S., Fernandes, J. F., Breton, M. E. S., Gowdy, W., Brodeur, S. E., Maccoy, M. C., & Brennan, T. A. (2009) · Journal of Palliative Medicine · doi:10.1089/jpm.2009.0089 · Cited by 73
Access before Approval — A Right to Take Experimental Drugs?
Okie, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmp068132 · Cited by 67
Setting Goals to Maintain Hope
Roenn, J. H. V., & von Gunten, C. F. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.161 · Cited by 63
Booth, C. M., & Tannock, I. F. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.8156 · Cited by 62
Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials
Vardy, J. L., Dadasovich, R., Beale, P. J., Boyer, M. J., & Clarke, S. J. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-130 · Cited by 43
Explaining Marginal Benefits to Patients, When “Marginal” Means Additional but Not Necessarily Small
Smith, T. J., & Hillner, B. E. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1278 · Cited by 25
Self-citationSomer, R. A., Sherman, E. J., & Langer, C. J. (2008) · Clinical Lung Cancer · doi:10.3816/clc.2008.n.015 · Cited by 24
Communication preferences and needs of cancer patients: the importance of content
Surbone, A. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-006-0027-8 · Cited by 17
Swetz, K. M., & Smith, T. J. (2010) · The Cancer Journal · doi:10.1097/ppo.0b013e3181f28ab3 · Cited by 14
Self-citationHarrington, S. E., & Smith, T. J. (2010) · Community Oncology · doi:10.1016/s1548-5315(11)70009-2 · Cited by 3
Self-citation
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Patients’ expectations about effects of chemotherapy for advanced cancer
Weeks, J. C., Catalano, P. J., Cronin, A., Finkelman, M. D., Mack, J. W., Keating, N. L., & Schrag, D. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204410 · Cited by 1,149
Integration of oncology and palliative care: a Lancet Oncology Commission
Kaasa, S., Loge, J. H., Aapro, M., Albreht, T., Anderson, R., Bruera, E., Brunelli, C., Caraceni, A., Cervantes, A., Currow, D. C., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30415-7 · Cited by 830
Early palliative care for adults with advanced cancer
Haun, M. W., Estel, S., Rücker, G., Friederich, H.-C., Villalobos, M., Thomas, M., & Hartmann, M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011129.pub2 · Cited by 757
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 4.2016
Ettinger, D. S., Wood, D. E., Akerley, W., Bazhenova, L. A., Borghaei, H., Camidge, D. R., Cheney, R. T., Chirieac, L. R., D'Amico, T. A., Dilling, T. J., et al. (2016) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2016.0031 · Cited by 736
Metadata
- Authors
- Peppercorn, J. M., Smith, T. J., Helft, P. R., DeBono, D. J., Berry, S. R., Wollins, D. S., Hayes, D. M., Von Roenn, J. H., & Schnipper, L. E.
- Venue
- Journal of Clinical Oncology
- Published
- 2011-02-20
- Volume
- 29
- Issue
- 6
- Pages
- 755-760
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2165335733
- Cited by
- 524
- References
- 43
- FWCI
- 47.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.